ACELYRIN Stock Quote SLRN - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.58

Bid

1.91

Ask

2.61

Volume

782,120

2.54 Day's Range 2.62

1.845 52 Week Range 8.59

Market Cap

258.84M

Previous Close

2.65

Open

2.589

Last Trade

2.61

Last Trade Time

Financial Volume

$ 2,023,252

VWAP

2.5869

Average Volume (3m)

2,325,960

Shares Outstanding

100,325,569

Dividend Yield

PE Ratio

-0.69

Earnings Per Share (EPS)

-3.8

Revenue

Net Profit

-381.64M

Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in... Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company's lead product candidate is izokibep, a small protein therapeutic designed to inhibit IL-17A with high potency, which is in Phase 3 clinical trials for use in the treatment of Hidradenitis Suppurativa, Psoriatic Arthritis, and uveitis, as well as in Phase 2 clinical trials for use in the treatment of Axial Spondyloarthritis. It is also developing lonigutamab, a humanized immunoglobulin G1 (IgG1) monoclonal antibody against insulin-like growth factor 1 receptor, which is in Phase 1 clinical trials for use in the treatment of thyroid eye disease; and SLRN-517, a fully human IgG1 monoclonal antibody targeting c-KIT, which is in preclinical stage for use in the treatment of chronic urticaria. The company was incorporated in 2020 and is headquartered in Agoura Hills, California. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.acelyrin.com

Headquarters

Wilmington, Delaware, USA

Founded

ACELYRIN Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SLRN. The last closing price for ACELYRIN was $2.65. Over the last year, ACELYRIN shares have traded in a share price range of $ 1.845 to $ 8.59.

ACELYRIN currently has 100,325,569 shares outstanding. The market capitalization of ACELYRIN is $265.86 million. ACELYRIN has a price to earnings ratio (PE ratio) of -0.69.

FeaturedNorthstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Form 425 - Prospectuses and communications, business combinations

ACELYRIN and Alumis Reaffirm Strategic and Financial Rationale of Proposed Merger

Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS...

ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger

All-Stock Transaction with Alumis Maximizes Long-Term Value for ACELYRIN Stockholders LOS ANGELES, March 04...

Kuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to Contact Law Firm

Kuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to Contact Law Firm PR Newswire NEW YORK, Feb. 21...

Form 425 - Prospectuses and communications, business combinations

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.12	-4.44444444444	2.7	2.77	2.3	1965709	2.59280673	CS
4	0.52	25.2427184466	2.06	2.77	1.845	3334652	2.37726076	CS
12	-0.66	-20.3703703704	3.24	3.95	1.845	2325960	2.33892451	CS
26	-2.17	-45.6842105263	4.75	6.52	1.845	1422051	3.09171145	CS
52	-5.33	-67.3830594185	7.91	8.59	1.845	1267513	4.18596364	CS
156	-20.42	-88.7826086957	23	29.88	1.845	1184126	8.11074996	CS
260	-20.42	-88.7826086957	23	29.88	1.845	1184126	8.11074996	CS

SLRN - Frequently Asked Questions (FAQ)

What is the current ACELYRIN share price?

The current share price of ACELYRIN is $ 2.58

How many ACELYRIN shares are in issue?

ACELYRIN has 100,325,569 shares in issue

What is the market cap of ACELYRIN?

The market capitalisation of ACELYRIN is USD 265.86M

What is the 1 year trading range for ACELYRIN share price?

ACELYRIN has traded in the range of $ 1.845 to $ 8.59 during the past year

What is the PE ratio of ACELYRIN?

The price to earnings ratio of ACELYRIN is -0.69

What is the reporting currency for ACELYRIN?

ACELYRIN reports financial results in USD

What is the latest annual profit for ACELYRIN?

The latest annual profit of ACELYRIN is USD -381.64M

What is the registered address of ACELYRIN?

The registered address for ACELYRIN is 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the ACELYRIN website address?

The website address for ACELYRIN is www.acelyrin.com

Which industry sector does ACELYRIN operate in?

ACELYRIN operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAPSCapstone Holding Corp	$ 3.11 (1,144.00%)	74.5k
HMRHeidmar Maritime Holdings Corporation	$ 2.5599 (69.53%)	37.58M
RDFNRedfin Corporation	$ 9.76 (67.70%)	92.54M
CKPTCheckpoint Therapeutics Inc	$ 3.9895 (61.52%)	60.92M
STSSSharps Technology Inc	$ 0.4399 (48.26%)	591.61M
APEDSTKd 100 percent MSTR and 100 percent COIN ETF	$ 11.591 (-35.98%)	2.58k
SXTCChina SXT Pharmaceuticals Inc	$ 2.78 (-35.54%)	162.75k
PCLAPicoCELA Inc	$ 0.8499 (-35.12%)	866.6k
CONLGraniteShares ETF Trust GraniteShares	$ 15.685 (-34.86%)	8.63M
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF	$ 19.22 (-32.95%)	24.05M
STSSSharps Technology Inc	$ 0.4399 (48.26%)	591.61M
NVDANVIDIA Corporation	$ 106.98 (-5.07%)	364.12M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 7.3701 (-30.86%)	258.67M
TSLATesla Inc	$ 222.15 (-15.43%)	188.57M
TQQQProShares UltraPro QQQ	$ 59.81 (-11.27%)	155.18M